Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482–2494. https://doi.org/10.1056/NEJMra0706547

Article  CAS  PubMed  Google Scholar 

Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374:1356–1367. https://doi.org/10.1056/NEJMra1515442

Article  CAS  PubMed  Google Scholar 

Balaban CD, Yates BJ (2017) What is nausea? A historical analysis of changing views. Auton Neurosci 202:5–17. https://doi.org/10.1016/j.autneu.2016.07.003

Article  PubMed  Google Scholar 

Singh P, Yoon SS, Kuo B (2016) Nausea: a review of pathophysiology and therapeutics. Ther Adv Gastroenterol 9:98–112. https://doi.org/10.1177/1756283X15618131

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japan Society of Clinical Oncology Clinical practice guidelines for antiemesis (2015) version 2. Kanehara & Co., Ltd

Google Scholar 

Aapro M (2018) Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-introduction. Support Care Cancer 26(Supplement 1):3–4. https://doi.org/10.1007/s00520-018-4147-8

Article  PubMed  PubMed Central  Google Scholar 

Japan Society of Clinical Oncology Clinical practice guidelines for antiemesis (2010) version 1. Kanehara & Co., Ltd

Google Scholar 

Japan Society of Clinical Oncology Clinical practice guidelines for antiemesis (2023) version 3. Kanehara & Co., Ltd

Google Scholar 

Tamura K, Aiba K, Saeki T, Nakanishi Y, Kamura T, Baba H, Yoshida K, Yamamoto N, Kitagawa Y, Maehara Y, Shimokawa M, Hirata K, Kitajima M, CINV Study Group of Japan (2015) Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855–865. https://doi.org/10.1007/s10147-015-0786-7

Article  PubMed  Google Scholar 

Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(3):2343–2351. https://doi.org/10.1056/NEJMoa032709

Article  CAS  PubMed  Google Scholar 

Shimada Y, Yoshino M, Wakui A, Nakao I, Futatsuki K, Sakata Y, Kambe M, Taguchi T, Ogawa N (1993) Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer CPT-11 Gastrointestinal Cancer Study Group. J Clin Oncol 11(5):909–913. https://doi.org/10.1200/JCO.1993.11.5.909

Article  CAS  PubMed  Google Scholar 

Rambeau A, Cherifi F, Neviere Z, Licaj I, Clarisse B, Joly F (2021) Platinum-induced nausea and vomiting in patients treated for head and neck cancer. Bull Cancer 108(5):449–454. https://doi.org/10.1016/j.bulcan.2021.01.010

Article  PubMed  Google Scholar 

Walko CM, Lindley C (2005) Capecitabine: a review. Clin Ther 27:23–44. https://doi.org/10.1016/j.clinthera.2005.01.005doi:10.1016/j.clinthera.2005.01.005

Taguchi T, Morimoto K, Horikoshi N, Takashima S, Toge T, Kimura M, Sano M, Aoyama H, Ota J, Noguchi S, S-1 Cooperative Study Group (Breast Cancer Working Group) (1998) An early phase II clinical study of S-1 in patients with breast cancer. Gan To Kagaku Ryoho 25:1035–1043

CAS  PubMed  Google Scholar 

Kiryu Y (2021) Potential for big data analysis using AI in the field of clinical pharmacy. Yakugaku Zasshi 141:179–185. https://doi.org/10.1248/yakushi.20-00196-4

Article  CAS  PubMed  Google Scholar 

Hosomi K, Fujimoto M, Ushio K, Mao L, Kato J, Takada M (2018) An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs. PLoS One 13:e0204648. https://doi.org/10.1371/journal.pone.0204648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuo H, Endo K, Tanaka H, Onoda T, Ishii T (2024) Fact-finding survey and exploration of preventive drugs for antineoplastic drug-induced oral mucositis using the Japanese Adverse Drug Event Report Database. Sci Pharm 92:34. https://doi.org/10.3390/scipharm92020034

Van Puijenbroek EPEP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC (2002) A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 11(1):3–10. https://doi.org/10.1002/pds.668

Article  CAS  PubMed  Google Scholar 

Chen JJ, Wang SJ, Tsai CA, Lin CJ (2007) Selection of differentially expressed genes in microarray data analysis. Pharmacogenomics J 7(3):212–220. https://doi.org/10.1038/sj.tpj.6500412

Article  CAS  PubMed  Google Scholar 

Kennedy ABW, Sankey HR (1898) The thermal efficiency of steam engines. Report of the committee appointed to the council upon the subject of the definition of a standard or standards of thermal efficiency for steam engines: with an introductory note (including appendixes and plate at back of volume). Minutes Proc Inst Civ Eng 134:278–312

Google Scholar 

Shi Y, Lin P, Ho EY, Nock CJ (2017) Nivolumab-associated nausea and vomiting as an immune adverse event. Eur J Cancer 84:367–369. https://doi.org/10.1016/j.ejca.2017.07.029

Article  PubMed  Google Scholar 

Hegde A, Jayaprakash P, Couillault CA, Piha-Paul S, Karp D, Rodon J, Pant S, Fu S, Dumbrava EE, Yap TA, Subbiah V, Bhosale P, Coarfa C, Higgins JP, Williams ET, Wilson TF, Lim J, Meric-Bernstam F, Sumner E, Zain H, Nguyen D, Nguyen LM, Rajapakshe K, Curran MA, Hong DS (2021) A phase I dose-escalation study to evaluate the safety and tolerability of evofosfamide in combination with ipilimumab in advanced solid malignancies. Clin Cancer Res 27(11):3050–3060. https://doi.org/10.1158/1078-0432.CCR-20-4118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gibney GT, Kudchadkar RR, DeConti RC, Thebeau MS, Czupryn MP, Tetteh L, Eysmans C, Richards A, Schell MJ, Fisher KJ, Horak CE, Inzunza HD, Yu B, Martinez AJ, Younos I, Weber JS (2015) Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma. Clin Cancer Res 21(4):712–720. https://doi.org/10.1158/1078-0432.CCR-14-2468

Article  CAS  PubMed  Google Scholar 

Gaudy-Marqueste C, Monestier S, Franques J, Cantais E, Richard MA, Grob JJ (2013) A severe case of ipilimumab-induced guillain-barréGuillain-Barré syndrome revealed by an occlusive enteric neuropathy: a differential diagnosis for ipilimumab-induced colitis. J Immunother 36:77–78. https://doi.org/10.1097/CJI.0b013e31827807dd

Article  PubMed  Google Scholar 

Krawczyk K, Śladowska K, Holko P, Kawalec P (2023) Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis. Front Pharmacol 14:1223929. https://doi.org/10.3389/fphar.2023.1223929

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaufman B, Shapira-Frommer R, Schmutzler RK, Audeh MW, Friedlander M, Balmaña J, Mitchell G, Fried G, Stemmer SM, Hubert A, Rosengarten O, Steiner M, Loman N, Bowen K, Fielding A, Domchek SM (2015) Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J Clin Oncol 33:244–250. https://doi.org/10.1200/JCO.2014.56.2728

Article  CAS  PubMed  Google Scholar 

Schnell FM (2003) Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. Oncologist 8(2):187–198. https://doi.org/10.1634/theoncologist.8-2-187

Article  CAS  PubMed  Google Scholar 

Aapro M (2005) 5-HT(3)-receptor antagonists in the management of nausea and vomiting in cancer and cancer treatment. Oncology 69:97–109. https://doi.org/10.1159/000087979

Article  CAS  PubMed  Google Scholar 

Saif MW, Mehra R (2006) Incidence and management of bevacizumab-related toxicities in colorectal cancer. Expert Opin Drug Saf 5(4):553–566. https://doi.org/10.1517/14740338.5.4.553

Article  CAS  PubMed  Google Scholar 

Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592–603. https://doi.org/10.1038/nrc2442

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ito S, Miwa K, Hattori C, Aida T, Tsuchiya Y, Mori K (2021) Highly sensitive in vitro cytokine release assay incorporating high-density preculture. J Immunotoxicol 18:136–143. https://doi.org/10.1080/1547691X.2021.1984617

Article  CAS  PubMed